Description for SS-31 10mg-50mg Peptide.

Mitochondrial Rescue in a Vial: The Peptide That's Turning Back the Clock on Cellular Energy Decline

Picture a world where mitochondrial dysfunction—the silent driver behind aging, fatigue, metabolic collapse, and tissue degeneration—could be directly countered at its source. Not with broad antioxidants that scatter like confetti, but with a precision-targeted tetrapeptide that homes in on cardiolipin in the inner mitochondrial membrane, stabilizes electron transport, slashes oxidative damage, and restores ATP production efficiency. In controlled laboratory settings, researchers are witnessing exactly that phenomenon with the SS-31 10mg-50mg Peptide, a mitochondria-penetrating powerhouse that's redefining preclinical investigations into energy homeostasis, age-related decline, and degenerative disease models.

Known in scientific literature as Elamipretide (or Bendavia/MTP-131), this small, cell-permeable peptide is no ordinary compound—it's a breakthrough tool for dissecting and potentially reversing mitochondrial pathology at the molecular level. Offered in flexible 10mg to 50mg lyophilized formats through Cali BioLabs Peptides at Cali BioLab Peptide, the SS-31 10mg-50mg Peptide delivers exceptional ≥99% purity, batch-specific COAs, and rapid USA domestic shipping—everything serious researchers need to push the boundaries of bioenergetics and regenerative science.

If your lab is tackling oxidative stress, cardiac remodeling, neurodegeneration, sarcopenia, or any condition where mitochondrial failure plays a starring role, the SS-31 10mg-50mg Peptide could be the catalyst that transforms stalled data into groundbreaking insights. Let's explore why this peptide continues to dominate mitochondrial research discussions.

Strict Disclaimer: For laboratory and scientific research use only. Not for human consumption, therapeutic, diagnostic, veterinary, or any non-research applications. Strictly intended for qualified researchers conducting in-vitro, ex-vivo, or ethically approved animal model studies. Cali BioLabs Peptides prioritizes full regulatory compliance.

The Turning Point: Dr. Elena's Aged Mouse Model That Defied Expectations

In a university aging research center in the Pacific Northwest, Dr. Elena Vasquez had spent nearly a decade documenting the inexorable decline in skeletal muscle performance and cardiac output in aged rodents. Her baseline data was consistent but disheartening: mitochondrial respiration rates plummeted, ROS levels soared, exercise tolerance cratered, and redox stress markers painted a picture of irreversible entropy.

Standard interventions—coenzyme Q10, NAC, even exercise mimetics—offered modest benefits but never reversed the core deficits. Then Elena encountered a series of publications on a mitochondria-targeted tetrapeptide that selectively bound cardiolipin and optimized electron chain function without global antioxidant interference. Intrigued, she ordered the SS-31 10mg-50mg Peptide (starting with the 10mg vial for pilot dosing) from Cali BioLabs Peptides. The shipment arrived pristine, with third-party HPLC/MS confirmation of 99.7% purity.

Over an 8-week treatment protocol in 24-month-old C57BL/6 mice (equivalent to ~70 human years), Elena administered subcutaneous doses scaled from preclinical literature. The transformation was remarkable: treated animals showed restored ADP-stimulated respiration, normalized H₂O₂ emission, improved mitochondrial coupling efficiency, and a striking 30-50% increase in treadmill endurance compared to age-matched controls. Cardiac ejection fraction improved, skeletal muscle fiber cross-sectional area increased modestly, and oxidative damage markers (4-HNE, nitrotyrosine) dropped significantly.

Elena's paper, published in a high-impact aging journal, concluded that late-life SS-31 10mg-50mg Peptide intervention could "reverse" key bioenergetic deficits rather than merely slow progression. The work secured renewed NIH funding and sparked collaborations with neurodegeneration groups exploring similar mechanisms in brain tissue. That single peptide vial became the pivot point that turned a descriptive aging study into an interventional breakthrough.

Has a targeted molecular intervention ever unexpectedly rescued a failing model in your own research?

What Is the SS-31 10mg-50mg Peptide? – Core Structure and Mechanism

The SS-31 10mg-50mg Peptide (D-Arg-Dmt-Lys-Phe-NH₂) is a synthetic, aromatic-cationic tetrapeptide designed for rapid mitochondrial penetration and selective interaction with cardiolipin—an anionic phospholipid uniquely enriched in the inner mitochondrial membrane (IMM).

Key product specifications:

• Available Sizes: 10mg or 50mg sterile lyophilized powder per vial (choose based on study scale)
• Purity: ≥99% (third-party verified by HPLC and Mass Spectrometry)
• Molecular Weight: ~639.8 Da
• Form: White, fluffy lyophilized solid optimized for reconstitution
• Storage: -20°C long-term; 2-8°C after reconstitution with bacteriostatic water or PBS
• COA: Full batch-specific analytical certificate included

Mechanism of Action – SS-31 accumulates 1000–5000-fold in mitochondria due to its cationic charge and aromatic residues. It binds cardiolipin, stabilizes cristae architecture, prevents cardiolipin peroxidation, optimizes electron transport chain (ETC) supercomplex assembly, reduces proton leak, and lowers ROS production. Unlike broad antioxidants, SS-31 acts locally at the ETC-cardiolipin interface, restoring ATP synthesis efficiency without disrupting redox signaling.

This targeted action makes the SS-31 10mg-50mg Peptide uniquely suited for modeling mitochondrial rescue in diverse systems.

Why Researchers Are Prioritizing SS-31 10mg-50mg Peptide in Preclinical Work

Mitochondrial dysfunction underlies countless pathologies—aging sarcopenia, heart failure, neurodegeneration, metabolic syndrome, ischemia-reperfusion injury—and conventional therapies often fail to reach or protect this organelle effectively. SS-31 bridges that gap.

Preclinical highlights include:

• Reversal of age-related redox stress and improved exercise capacity in aged rodents
• Restoration of cardiac energetics and ejection fraction in old mice
• Neuroprotection in spinal cord injury, Alzheimer's-like, and Parkinson's models via reduced ROS and preserved synaptic integrity
• Amelioration of glomerular architecture and renal mitochondrial function in aged animals
• Mitigation of chemotherapy-induced cachexia by improving whole-body energy status
• Rescue of neurovascular coupling and cerebrovascular function in aging brain models

The SS-31 10mg-50mg Peptide excels because it addresses root-cause bioenergetic failure rather than downstream symptoms. Sourcing from Cali BioLabs Peptides ensures USA-certified manufacturing, fast shipping, secure checkout, and strict research-only framing—critical for grant compliance and data integrity.

How to Incorporate SS-31 10mg-50mg Peptide in Laboratory Protocols

Reconstitution is simple:

1. Equilibrate vial to room temperature.
2. Add 1–5 mL bacteriostatic water or sterile PBS (depending on desired stock concentration); gently swirl.
3. Prepare stocks (e.g., 5–10 mg/mL) and dilute for working use (typically 1–10 mg/kg in vivo or nM–μM in vitro).
4. Aliquot and freeze at -80°C for long-term stability.

Common research applications:

• In-vitro mitochondrial respiration assays (Oroboros, Seahorse) on isolated mitochondria or cells
• Chronic treatment in aged or disease-model rodents (subcutaneous, intraperitoneal, or osmotic pump delivery)
• Ex-vivo tissue slices (heart, brain, muscle) to assess bioenergetics post-ischemia
• Combination studies with other mitochondrial probes or stressors

Always use sterile technique and follow ethical guidelines.

Advantages of SS-31 10mg-50mg Peptide – A Researcher's Checklist

• Selective cardiolipin stabilization and ETC optimization
• Rapid mitochondrial uptake and high organelle concentration
• Reduction of oxidative damage without broad redox interference
• Reversal (not just slowing) of age-related mitochondrial deficits in models
• Flexible 10mg–50mg sizes for pilot through large-scale studies
• High purity and transparency minimizing variables
• USA-sourced, fast domestic shipping, researcher support
• Alignment with ethical research standards

Frequently Asked Questions About SS-31 10mg-50mg Peptide

Q: How does SS-31 compare to other mitochondrial antioxidants like MitoQ? A: SS-31 targets cardiolipin directly and optimizes ETC architecture, often showing superior effects on respiration and ROS in aging models compared to ubiquinone-based compounds.

Q: What dosing ranges are common in preclinical literature? A: Studies typically use 1–10 mg/kg/day subcutaneously in rodents; higher acute doses appear in some ischemia models.

Q: Is SS-31 stable after reconstitution? A: Yes—stable for weeks at 2–8°C; freeze aliquots for extended storage.

Q: Can it be used in combination with GLP-1 analogs or exercise mimetics? A: Emerging data suggest additive benefits in metabolic and aging models.

Q: How do I verify batch quality? A: Match the provided COA to numbers on the product page.

Q: Suitable for neurodegeneration models? A: Yes—strong preclinical evidence in Alzheimer's-like, Parkinson's, and spinal cord injury paradigms.

What Mitochondrial Mystery Could SS-31 10mg-50mg Peptide Help You Solve?

With mitochondrial dysfunction implicated in virtually every chronic disease, what specific energetic deficit, oxidative pathway, or tissue resilience question might the SS-31 10mg-50mg Peptide illuminate in your lab? Could it redefine your understanding of late-life intervention windows or synergistic therapies?

Share your research vision—the conversation drives progress.

In summary, the SS-31 10mg-50mg Peptide from Cali BioLab Peptides is a precision-engineered tool for probing and potentially rescuing mitochondrial health. Exceptional purity, reliable supply, and proven utility in advanced models position it as a must-have for 2026 bioenergetics research.

Order your SS-31 10mg-50mg Peptide today at Cali BioLab Peptides and energize your experiments with confidence.